Research graph
References from Therapeutic Potential of SAT-3247 in a Canine Model of Duchenne Muscular Dystrophy. Local targets link to admitted publications; unresolved targets remain external evidence.
The protein product of the duchenne muscular dystrophy locus
10.1016/0092-8674(87)90579-4 · 1987 · External reference
Duchenne muscular dystrophy
10.1038/s41572-021-00248-3 · 2021 · External reference
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
10.1016/0092-8674(87)90579-4 · 1987 · External reference
The muscular dystrophies
10.1016/s0140-6736(02)07815-7 · 2002 · External reference
Membrane organization of the dystrophin-glycoprotein complex
10.1016/0092-8674(91)90035-w · 1991 · External reference
Aberrant repair and fibrosis development in skeletal muscle
10.1186/2044-5040-1-21 · 2011 · External reference
Numb is required to prevent p53-dependent senescence following skeletal muscle injury
10.1038/ncomms9528 · 2015 · External reference
Intrinsic and extrinsic mechanisms regulating satellite cell function
10.1242/dev.114223 · 2015 · External reference
The Dystrophin Glycoprotein Complex Regulates the Epigenetic Activation of Muscle Stem Cell Commitment
10.1016/j.stem.2018.03.022 · 2018 · External reference
Satellite Cells in Muscular Dystrophy – Lost in Polarity
10.1016/j.molmed.2016.04.002 · 2016 · External reference
Intrinsic dysfunction in muscle stem cells lacking dystrophin begins during secondary myogenesis
10.1038/s41467-025-64999-3 · 2025 · External reference
Therapeutic options for Duchenne muscular dystrophy: hope or hype?
10.1177/17562864251346326 · 2025 · External reference
Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy
10.1007/s00415-026-13711-6 · 2026 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Independent Canine Models of Duchenne Muscular Dystrophy Due to Intronic Insertions of Repetitive DNA
10.1016/s1525-0016(16)44336-4 · 2007 · External reference
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models
10.1038/s41467-021-26830-7 · 2021 · External reference
10.1007/978-1-0716-4811-7_14
10.1007/978-1-0716-4811-7_14 · 2026 · External reference
Regenerative Index: a method to assess muscle regeneration in patients with Duchenne muscular dystrophy
10.1186/s13395-026-00436-3 · External reference
Regenerative Index: a method to assess muscle regeneration in patients with Duchenne muscular dystrophy
10.1186/s13395-026-00436-3 · External reference
The Paradox of Muscle Hypertrophy in Muscular Dystrophy
10.1016/j.pmr.2011.11.014 · 2012 · External reference
Systemic Delivery of Allogenic Muscle Stem Cells Induces Long-Term Muscle Repair and Clinical Efficacy in Duchenne Muscular Dystrophy Dogs
10.1016/j.ajpath.2011.07.022 · 2011 · External reference
10.1007/978-1-0716-2772-3_5
10.1007/978-1-0716-2772-3_5 · 2023 · External reference
Contraction force generated by tarsal joint flexion and extension in dogs with golden retriever muscular dystrophy
10.1016/s0022-510x(99)00118-5 · 1999 · External reference
Altered myofilament structure and function in dogs with Duchenne muscular dystrophy cardiomyopathy
10.1016/j.yjmcc.2017.12.008 · 2018 · External reference
Ambulatory electrocardiographic longitudinal monitoring in a canine model for Duchenne muscular dystrophy identifies decreased very low frequency power as a hallmark of impaired heart rate variability
10.1038/s41598-024-59196-z · 2024 · External reference
Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical Trials
10.1093/ilar/ilu011 · 2014 · External reference
10.1007/978-1-0716-2772-3_18
10.1007/978-1-0716-2772-3_18 · 2023 · External reference
10.1371/journal.pone.0194485
10.1371/journal.pone.0194485 · 2018 · External reference
The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy
10.12688/wellcomeopenres.18251.1 · 2022 · External reference
Quantitative analysis of approximate shapes in a myofiber cross-section and their relationship with myofiber cross-sectional area
10.1589/jpts.33.931 · 2021 · External reference
Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy
10.1161/jaha.119.012443 · 2019 · External reference
10.1371/journal.pone.0300827
10.1371/journal.pone.0300827 · 2024 · External reference
Circulatory CCL2 distinguishes Duchenne muscular dystrophy dogs
10.1242/dmm.052137 · 2025 · External reference
Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy
10.1155/2014/965631 · 2014 · External reference
Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
10.3389/fphys · 2023 · External reference
Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy
10.1242/dmm.049394 · 2022 · External reference
Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype
10.1093/hmg/ddq523 · 2011 · External reference
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
10.1007/s00335-011-9382-y · 2012 · External reference
Duchenne Muscular Dystrophy Gene Therapy in the Canine Model
10.1089/humc.2015.006 · 2015 · External reference
Transcriptional changes of genes encoding sarcoplasmic reticulum calcium binding and up-taking proteins in normal and Duchenne muscular dystrophy dogs
10.1186/s12891-024-07927-8 · 2024 · External reference
10.1007/978-1-0716-2772-3_18
10.1007/978-1-0716-2772-3_18 · ExternalCitation · doi-reference
10.1007/978-1-0716-2772-3_5
10.1007/978-1-0716-2772-3_5 · ExternalCitation · doi-reference
10.1007/978-1-0716-4811-7_14
10.1007/978-1-0716-4811-7_14 · ExternalCitation · doi-reference
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
10.1007/s00335-011-9382-y · ExternalCitation · doi-reference
Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy
10.1007/s00415-026-13711-6 · ExternalCitation · doi-reference
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
10.1016/0092-8674(87)90579-4 · ExternalCitation · doi-reference
Membrane organization of the dystrophin-glycoprotein complex
10.1016/0092-8674(91)90035-w · ExternalCitation · doi-reference
Systemic Delivery of Allogenic Muscle Stem Cells Induces Long-Term Muscle Repair and Clinical Efficacy in Duchenne Muscular Dystrophy Dogs
10.1016/j.ajpath.2011.07.022 · ExternalCitation · doi-reference
Satellite Cells in Muscular Dystrophy – Lost in Polarity
10.1016/j.molmed.2016.04.002 · ExternalCitation · doi-reference
The Paradox of Muscle Hypertrophy in Muscular Dystrophy
10.1016/j.pmr.2011.11.014 · ExternalCitation · doi-reference
The Dystrophin Glycoprotein Complex Regulates the Epigenetic Activation of Muscle Stem Cell Commitment
10.1016/j.stem.2018.03.022 · ExternalCitation · doi-reference
Altered myofilament structure and function in dogs with Duchenne muscular dystrophy cardiomyopathy
10.1016/j.yjmcc.2017.12.008 · ExternalCitation · doi-reference
Contraction force generated by tarsal joint flexion and extension in dogs with golden retriever muscular dystrophy
10.1016/s0022-510x(99)00118-5 · ExternalCitation · doi-reference
The muscular dystrophies
10.1016/s0140-6736(02)07815-7 · ExternalCitation · doi-reference
Independent Canine Models of Duchenne Muscular Dystrophy Due to Intronic Insertions of Repetitive DNA
10.1016/s1525-0016(16)44336-4 · ExternalCitation · doi-reference
Numb is required to prevent p53-dependent senescence following skeletal muscle injury
10.1038/ncomms9528 · ExternalCitation · doi-reference
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models
10.1038/s41467-021-26830-7 · ExternalCitation · doi-reference
Intrinsic dysfunction in muscle stem cells lacking dystrophin begins during secondary myogenesis
10.1038/s41467-025-64999-3 · ExternalCitation · doi-reference
Duchenne muscular dystrophy
10.1038/s41572-021-00248-3 · ExternalCitation · doi-reference
Ambulatory electrocardiographic longitudinal monitoring in a canine model for Duchenne muscular dystrophy identifies decreased very low frequency power as a hallmark of impaired heart rate variability
10.1038/s41598-024-59196-z · ExternalCitation · doi-reference
Duchenne Muscular Dystrophy Gene Therapy in the Canine Model
10.1089/humc.2015.006 · ExternalCitation · doi-reference
Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype
10.1093/hmg/ddq523 · ExternalCitation · doi-reference
Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical Trials
10.1093/ilar/ilu011 · ExternalCitation · doi-reference
Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy
10.1155/2014/965631 · ExternalCitation · doi-reference
Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy
10.1161/jaha.119.012443 · ExternalCitation · doi-reference
Therapeutic options for Duchenne muscular dystrophy: hope or hype?
10.1177/17562864251346326 · ExternalCitation · doi-reference
Aberrant repair and fibrosis development in skeletal muscle
10.1186/2044-5040-1-21 · ExternalCitation · doi-reference
Transcriptional changes of genes encoding sarcoplasmic reticulum calcium binding and up-taking proteins in normal and Duchenne muscular dystrophy dogs
10.1186/s12891-024-07927-8 · ExternalCitation · doi-reference
Regenerative Index: a method to assess muscle regeneration in patients with Duchenne muscular dystrophy
10.1186/s13395-026-00436-3 · ExternalCitation · doi-reference
Intrinsic and extrinsic mechanisms regulating satellite cell function
10.1242/dev.114223 · ExternalCitation · doi-reference
Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy
10.1242/dmm.049394 · ExternalCitation · doi-reference
Circulatory CCL2 distinguishes Duchenne muscular dystrophy dogs
10.1242/dmm.052137 · ExternalCitation · doi-reference
The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy
10.12688/wellcomeopenres.18251.1 · ExternalCitation · doi-reference
10.1371/journal.pone.0194485
10.1371/journal.pone.0194485 · ExternalCitation · doi-reference
10.1371/journal.pone.0300827
10.1371/journal.pone.0300827 · ExternalCitation · doi-reference
Quantitative analysis of approximate shapes in a myofiber cross-section and their relationship with myofiber cross-sectional area
10.1589/jpts.33.931 · ExternalCitation · doi-reference
Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
10.3389/fphys · ExternalCitation · doi-reference
